Anti Islet Cell Antibody With titer, Serum

Anti Islet Cell Antibody with Titer, Serum

Test Overview

The Anti Islet Cell Antibody (ICA) with Titer, Serum test detects autoantibodies directed against the insulin-producing islet cells of the pancreas. It is primarily used to help diagnose Type 1 Diabetes Mellitus (T1DM) and evaluate individuals at risk of developing autoimmune diabetes. The antibody titer provides an estimate of the antibody concentration, which may aid in clinical assessment.

Why is this Test Done?

• Helps diagnose Type 1 Diabetes Mellitus (T1DM).
• Differentiates Type 1 diabetes from Type 2 diabetes.
• Assesses autoimmune destruction of pancreatic beta cells.
• Supports evaluation of Latent Autoimmune Diabetes in Adults (LADA).
• Screens first-degree relatives of individuals with Type 1 diabetes who may be at increased risk.
• Assists in monitoring autoimmune diabetes when interpreted with other antibody tests.

When is this Test Recommended?

Your healthcare provider may recommend this test if you have:

• Increased thirst and frequent urination.
• Unexplained weight loss.
• Persistent fatigue.
• High blood sugar levels with suspected autoimmune diabetes.
• Family history of Type 1 diabetes.
• Newly diagnosed diabetes requiring classification.

Sample Required

• Sample Type: Serum
• Preparation: No fasting is usually required unless advised by your physician.

Understanding the Results

• Negative: No detectable islet cell antibodies; autoimmune Type 1 diabetes is less likely, though not completely excluded.
• Positive (Low Titer): Suggests autoimmune activity against pancreatic islet cells.
• Positive (High Titer): Strongly supports autoimmune Type 1 diabetes and may indicate a higher risk of disease progression in susceptible individuals.

Note: Results should always be interpreted alongside clinical findings and other diabetes-related autoantibody tests such as GAD65, IA-2, ZnT8, and Insulin Autoantibodies (IAA).

Who Should Consider This Test?

• Children and adults with newly diagnosed diabetes.
• Individuals with suspected autoimmune diabetes.
• People with a family history of Type 1 diabetes.
• Patients suspected of having LADA.
• Individuals enrolled in diabetes risk assessment programs.

Test Benefits

• Early detection of autoimmune diabetes.
• Helps classify the type of diabetes accurately.
• Supports timely treatment decisions.
• Assists in identifying individuals at increased risk before symptoms develop.
• Valuable when combined with other pancreatic autoantibody tests.

Early identification of autoimmune diabetes helps guide appropriate treatment and improve long-term diabetes management.